Utilization Management Letters
Featured Letters
Below are some of our featured letters on Utilization Management that highlight our recent work and victories.
To see all of our letters on this topic, scroll down to the archive section.
Federal Step Therapy
NPF submits coalition letter asking Congress to include step therapy protections in next COVID-19 relief legislative package
Read moreFederal Step Therapy
NPF submits coalition letter to Congress in support of the Safe Step Act.
Read moreState Step Therapy
NPF submits letter in support of Louisiana step therapy bill HB 263 to House Committee on Insurance.
Read moreState Utilization Management
NPF submits letter of support for Washington utilization management bill HB 1879 to Senate Health & Long-Term Care Committee.
Read moreState Prior Authorization
NPF submits letter of support for proposed rule on Oregon prior authorization bill SB 249 to Department of Consumer and Business Services.
Read moreFederal Step Therapy
NPF adds name to coalition letter to CMS regarding step therapy in Medicare Advantage Plans.
Read moreFederal Letters on Utilization Management
2020
● 12/04/2020 - NPF Submits Coalition Letter Urging Congress to Enact the Safe Step Act By End of 116th Congress
● 05/29/2020 - NPF Submits Coalition Letter to CMS Asking for Step Therapy Flexibilities During the Public Health Emergency
● 04/20/2020 - NPF Submits Coalition Letter Asking Congress to Include Step Therapy Protections in Next COVID-19 Relief Legislative Package
● 04/10/2020 - NPF Adds Name to Coalition Letter Calling on CMS to Reduce Medical Necessity Standards for Step Therapy and Prior Authorization During a Pandemic
● 03/06/2020 - NPF Submits Coalition Letter to Congress in Support of the Safe Step Act
2019
● 04/08/19 - NPF Adds Name to Coalition Letter to CMS Regarding Step Therapy in Medicare Advantage Plans
State Letters on Utilization Management
2021
● 03/01/2021 - NPF Submits Letter in Support of Oregon Utiliziation Management Reform
2020
● 10/26/2020 - NPF Drafts Coalition Comment Letter Regarding Washington State's Proposed Rule on Prescription Drug Utilization Management
● 07/27/20 - NPF submits commit letter with guiding principles on step therapy reform encouraging the Nevada legislature to take up the issue in 2021
● 06/02/2020 - Louisiana Coalition Asks Governor Edwards to Enact HB 263 to Improve Step Therapy in Louisiana
● 05/28/2020 - NPF Joins Coalition in Asking Louisiana Senate to Support HB 263 to Strengthen Step Therapy Protections
● 05/27/2020 - NPF Submits Letter in Support of Louisiana Step Therapy Bill HB 263 to Senate Insurance Committee
● 05/25/2020 - NPF Joins Coalition in Asking the Louisiana Senate Committee on Insurance to Support Step Therapy Protections (HB 263)
● 05/15/2020 - NPF Submits Letter Commenting on Michigan Medicaid Common Formulary and Utilization Management
● 05/13/2020 - NPF Joins Coalition in Thanking Louisiana House Insurance Committee for Unanimously Passing Step Therapy Protections HB 263
● 05/13/2020 - NPF Submits Letter in Support of Louisiana Step Therapy Bill HB 263 to House Committee on Insurance
● 05/12/2020 - NPF Adds Name to Louisiana Coalition Letter in Support of Step Therapy HB 263 for House Insurance Committee
● 04/22/2020 - NPF Submits Letter in Support of California Step Therapy AB 2144 to Assembly Committee on Health
● 03/03/2020 - NPF Submits Letter in Support of South Dakota Step Therapy Bill SB 155 to House Health and Human Services Committee
● 02/24/2020 - NPF Submits Letter in Support of Oregon Step Therapy Bill HB 4102 to Senate Committee on Healthcare
● 02/12/2020 - NPF Testifies in Support of SB 155 to Create Step Therapy Protections in South Dakota
● 02/03/2020 - NPF Submits Letter in Support of Oregon Utilization Management Bill HB 4102 to House Committee on Healthcare
● 02/03/2020 - NPF Submits Letter in Support of Arizona Step Therapy Bill HB 4102 to House Committee on Health & Human Services
● 01/27/2020 - NPF Submits Comment Letter on Wisconsin Step Therapy Rulemaking Process
2019
● 12/30/19 - NPF Submits Letter of Concern with Rulemaking on Washington Bill EHB 1879 to Office of the Insurance Commissioner
● 08/30/19 - NPF Submits Letter of Support for Proposed Rule on Oregon Prior Authorization Bill SB 249 to Department of Consumer and Business Services
● 06/10/19 - NPF Submits Coalition Letter in Support for Proposed Amended Regulation to Colorado Department of Regulatory Agencies
● 05/13/19 - NPF Submits Letter of Support for Delaware Step Therapy Bill HB 105 to Senate Full Chamber
● 04/23/19 - NPF Submits Letter of Support for Rhode Island Step Therapy Bill HB 5806 to House Committee on Health, Education & Welfare
● 04/15/19 - NPF Submits Letter of Support for North Carolina Bill HB 450 for House Health Committee
● 04/08/19 - NPF Submits Letter of Support for Montana Prior Authorization Bill HB 555 to Senate Committee on Public Health, Welfare and Safety
● 03/12/19 - NPF Submits Letter of Support for Utah Prior Authorization Bill SB 264 to House Rules Committee
● 02/21/19 - NPF Submits Letter of Support for Washington Utilization Management Bill HB 1879 to Senate Health & Long-Term Care Committee
● 02/08/19 - NPF Signs on in Support of Virginia Step Therapy HB 2126 to Senate Commerce and Labor Committee
● 2019 - NPF Adds Name to Coalition Letter to the Ohio Federal Congressional Delegation Regarding Step Therapy
Out-of-Pocket Costs
High out-of-pocket costs are all too often a barrier to care. NPF supports policies to lower out-of-pocket costs for our community.
Letters on Out-of-Pocket CostsOther Policy Areas
Whether it’s value-based care, telehealth, or protections for pre-existing conditions, NPF advocacy is weighing in to ensure the psoriatic disease community is heard.
Letters on Other Policy Areas